Laura Board

Laura Board is The Deal’s international editor. Based in London, she leads a team producing news and features on corporate finance and regulation from Brussels to Brisbane. Board joined the The Deal shortly after its 1999 launch from the Financial Times. Before that, she worked at Bloomberg News in Frankfurt and London and at Retail Week. She speaks French, Italian, German and Spanish.

Recent Articles By The Author

Comcast Beats Quarterly Forecasts as Video Subscribers, Revenue-per-Customer Rise

Comcast Beats Quarterly Forecasts as Video Subscribers, Revenue-per-Customer Rise

A new Harry Potter-themed attraction pushes theme park sales up 61%.

Lloyds Shares Fall as Provisions Eat into Quarterly Profit

Lloyds Shares Fall as Provisions Eat into Quarterly Profit

But the U.K. lender stands by its financial targets and reports better-than-expected capital generation in the third quarter.

Provisions, Restructuring News Top RBS Investors' Quarterly Wish List

Provisions, Restructuring News Top RBS Investors' Quarterly Wish List

Shareholders will also strain for information on the post-Brexit outlook at the Edinburgh lender.

Merck Lifts Full-Year Guidance After Quarterly Forecast Beat

Merck Lifts Full-Year Guidance After Quarterly Forecast Beat

The group's Keytruda immunotherapy boosts pharmaceuticals sales.

German Business Confidence Busts Forecasts to Hit 30-Month High

German Business Confidence Busts Forecasts to Hit 30-Month High

The stronger-than-expected data, following robust German purchasing managers' indices on Monday, fuel optimism about the fourth-quarter outlook..

Earnings Reports Propel European Stocks Higher but AMS Plunges

Earnings Reports Propel European Stocks Higher but AMS Plunges

The chip maker sinks on news of production problems and a gloomy fourth-quarter prognosis.

Novartis Beats Third-Quarter Earnings Forecasts on Growth Products, Cost Cuts

Novartis Beats Third-Quarter Earnings Forecasts on Growth Products, Cost Cuts

The group's blood cancer drug Gleevec also holds up better than expected against generic competition.

Syngenta Warns of Delay in $43 Billion Takeover by ChemChina

Syngenta Warns of Delay in $43 Billion Takeover by ChemChina

The Swiss fertilizers maker says regulators in the EU and elsewhere have demanded more information.

TD Ameritrade, TD Bank Mount $4 Billion Bid for Scottrade

TD Ameritrade, TD Bank Mount $4 Billion Bid for Scottrade

The complex transaction will add a fifth to TD Ameritrade's client assets.

Eurozone PMI Pickup Masks German, French Divergence

Eurozone PMI Pickup Masks German, French Divergence

Markit says the data, which follow disappointing September numbers, are consistent with 0.4% quarterly GDP growth.